These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 8222122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
    [Abstract] [Full Text] [Related]

  • 3. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators.
    Pouleur H, Rousseau MF, van Eyll C, Stoleru L, Hayashida W, Udelson JA, Dolan N, Kinan D, Gallagher P, Ahn S.
    Circulation; 1993 Aug; 88(2):481-91. PubMed ID: 8101772
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction. The SOLVD Investigators.
    Konstam MA, Kronenberg MW, Udelson JE, Kinan D, Metherall J, Dolan N, Edens T, Howe D, Kilcoyne L, Benedict C.
    Am J Cardiol; 1992 Jun 15; 69(19):1591-5. PubMed ID: 1598875
    [Abstract] [Full Text] [Related]

  • 5. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.
    Patten RD, Kronenberg MW, Benedict CR, Udelson JE, Kinan D, Stewart D, Yusuf S, Smith JJ, Kilcoyne L, Dolan N, Edens TR, Metherall J, Konstam MA.
    Am Heart J; 1997 Jul 15; 134(1):37-43. PubMed ID: 9266781
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.
    Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, Shelton B.
    Circulation; 1995 May 15; 91(10):2573-81. PubMed ID: 7743619
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Radionuclide monitoring of cardiac adaptations to volume loading in patients with dilated cardiomyopathy and mild heart failure. Effects of angiotensin-converting enzyme inhibition.
    Volpe M, Rao MA, Cuocolo A, Russo R, Nappi A, Mele AF, Enea I, Trimarco B, Condorelli M.
    Circulation; 1995 Nov 01; 92(9):2511-8. PubMed ID: 7586352
    [Abstract] [Full Text] [Related]

  • 9. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG, Crozier IG, Turner JG, Richards AM, Frampton CM, Nicholls MG, Ikram H.
    Am J Cardiol; 1994 Jun 15; 73(16):1180-6. PubMed ID: 8203335
    [Abstract] [Full Text] [Related]

  • 10. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W, Tighiouart H, Ku E, Salem D, Sarnak MJ.
    Am J Kidney Dis; 2020 Jan 15; 75(1):21-29. PubMed ID: 31303349
    [Abstract] [Full Text] [Related]

  • 11. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: modification by long-term enalapril treatment. The SOLVD Investigators.
    Hayashida W, Van Eyll C, Rousseau MF, Pouleur H.
    J Am Coll Cardiol; 1993 Nov 01; 22(5):1403-10. PubMed ID: 8227798
    [Abstract] [Full Text] [Related]

  • 12. Contractile state is the major determinant of functional outcome in patients with left ventricular dysfunction treated with enalapril.
    Mirsky I, Aoyagi T, Ihara T, van Eyll C, Rousseau MF, Pouleur H.
    Eur Heart J; 1995 Jun 01; 16(6):808-17. PubMed ID: 7588925
    [Abstract] [Full Text] [Related]

  • 13. Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators.
    Pouleur HG, Konstam MA, Udelson JE, Rousseau MF.
    J Am Coll Cardiol; 1993 Oct 01; 22(4 Suppl A):43A-48A. PubMed ID: 8376696
    [Abstract] [Full Text] [Related]

  • 14. An angiotensin-converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with beta-thalassemia major.
    Karvounis HI, Zaglavara TA, Parharidis GE, Nouskas IG, Hassapopoulou EP, Gemitzis KD, Louridas GE.
    Am Heart J; 2001 Feb 01; 141(2):281. PubMed ID: 11174351
    [Abstract] [Full Text] [Related]

  • 15. Early treatment with low-dose enalapril after acute myocardial infarction: an equilibrium radionuclide angiographic study. Enalapril despues del Infarto (EDI) Trial Investigators.
    Bazzino O, Navarro Estrada JL, Sosa Liprandi A, Presti C, Masoli O, Santopinto J, Ahuad A, Amuchástegui M, Méndez R.
    J Nucl Cardiol; 1997 Feb 01; 4(2 Pt 1):133-9. PubMed ID: 9115065
    [Abstract] [Full Text] [Related]

  • 16. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
    Sabbah HN, Shimoyama H, Kono T, Gupta RC, Sharov VG, Scicli G, Levine TB, Goldstein S.
    Circulation; 1994 Jun 01; 89(6):2852-9. PubMed ID: 8205701
    [Abstract] [Full Text] [Related]

  • 17. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
    Dittrich S, Graf E, Trollmann R, Neudorf U, Schara U, Heilmann A, von der Hagen M, Stiller B, Kirschner J, Pozza RD, Müller-Felber W, Weiss K, von Au K, Khalil M, Motz R, Korenke C, Lange M, Wilichowski E, Pattathu J, Ebinger F, Wiechmann N, Schröder R, German Competence Network for Congenital Heart Defects and the Treat-NMD Neuromuscular Network Investigators list of additional local Investigators and co-workers of the German Competence Network for Congenital Heart Defects and the Treat-NMD Neuromuscular Network.
    Orphanet J Rare Dis; 2019 May 10; 14(1):105. PubMed ID: 31077250
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS, Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators.
    Am J Cardiol; 2005 Sep 01; 96(5):698-704. PubMed ID: 16125499
    [Abstract] [Full Text] [Related]

  • 19. Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction.
    Romano M, Cardei S, de Arcangelis E, Monteforte I, Capaldo M, Muto P, Marchegiano R, Kilama MO, Condorelli M.
    Am Heart J; 1997 Mar 01; 133(3):268-72. PubMed ID: 9060793
    [Abstract] [Full Text] [Related]

  • 20. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
    Böhm M, Pogue J, Kindermann I, Pöss J, Koon T, Yusuf S.
    Eur J Heart Fail; 2014 Mar 01; 16(3):325-33. PubMed ID: 24464788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.